| Ident. | Authors (with country if any) | Title |
|---|
| 001119 |
F. Tubach [France] ; P. Ravaud [France] ; E. Martin-Mola [Espagne] ; H. Awada [Liban] ; N. Bellamy [Australie] ; C. Bombardier [Canada] ; D. T. Felson [États-Unis] ; N. Hajjaj-Hassouni [Maroc] ; M. Hochberg [États-Unis] ; I. Logeart [France] ; M. Matucci-Cerinic [Italie] ; M. Van De Laar [Pays-Bas] ; D. Van Der Heijde [Pays-Bas] ; M. Dougados [France] | Minimum Clinically Important Improvement and Patient Acceptable Symptom State in Pain and Function in Rheumatoid Arthritis, Ankylosing Spondylitis, Chronic Back Pain, Hand Osteoarthritis, and Hip and Knee Osteoarthritis: Results From a Prospective Multinational Study |
| 001887 |
Laure Gossec [France, Canada, Suède, États-Unis, Royaume-Uni, Australie, République tchèque, Italie] ; Gillian Hawker [France, Canada] ; Aileen M. Davis [Canada] ; Jean Francis Maillefert [France] ; L. Stefan Lohmander ; Roy Altman ; Jolanda Cibere ; Philip G. Conaghan ; Marc C. Hochberg ; Joanne M. Jordan ; Jeffrey N. Katz ; Lyn March ; Nizar Mahomed ; Karel Pavelka ; Ewa M. Roos ; Maria E. Suarez-Almazor ; Gustavo Zanoli ; Maxime Dougados | OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis |
| 001A39 |
F. Tubach [France] ; P. Ravaud [France] ; G. Baron [France] ; B. Falissard [France] ; I. Logeart [France] ; N. Bellamy [Australie] ; C. Bombardier [Canada] ; D. Felson [États-Unis] ; M. Hochberg [États-Unis] ; D. Van Der Heijde [Pays-Bas] ; M. Dougados [France] | Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement |
| 001D44 |
N. Bellamy [Canada, Royaume-Uni, Pays-Bas, Australie, États-Unis, France] ; J. Kirwan ; M. Boers ; P. Brooks ; V. Strand ; P. Tugwell ; R. Altman ; K. Brandt ; M. Dougados ; M. Lequesne | Recommendations for a core set of outcome measures for future Phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III |
